baclofen has been researched along with Brain Disorders in 30 studies
Excerpt | Relevance | Reference |
---|---|---|
" He developed acute kidney injury at hospital secondary to vancomycin use, and mental status declined." | 5.05 | Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature. ( Abraham, M; Behmer Hansen, R; Gold, J; Lad, M; Mammis, A; Zhao, K, 2020) |
"A 69-year-old woman with a history of hemodialysis-dependent end-stage renal disease presented to the Emergency Department with encephalopathy, ataxia, and dystonia after the addition of a recent baclofen prescription for back pain (10 mg twice daily)." | 3.85 | Baclofen Toxicity in a Patient with Hemodialysis-Dependent End-Stage Renal Disease. ( Katz, KD; Merrick, SS; Porter, LM, 2017) |
"Intrathecal baclofen therapy is increasingly used to alleviate medically intractable spasticity in children with cerebral palsy, spinal cord injuries, and generalized dystonia." | 3.73 | Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features. ( Adirim, TA; Darbari, FP; Kothare, SV; Melvin, JJ; Piatt, JH, 2005) |
" The dosage of ITB increased from a mean of 157 microg/day 3 months after pump insertion to 300 microg/day at 2 years postimplantation, and remained relatively stable thereafter." | 2.71 | Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. ( Albright, AL; Gilmartin, R; Ivanhoe, CB; Krach, LE; McLaughlin, JF; Swift, D, 2003) |
"Improvement was reported in spasticity, spasms, pain, gait, activities of daily life and providing care." | 2.48 | Intrathecal baclofen for progressive neurological disease in childhood: a systematic review of literature. ( Becher, JG; Bonouvrié, LA; van Ouwerkerk, WJ; van Schie, PE; Vermeulen, RJ, 2012) |
"The term cerebral palsy is restricted to non-progressive disorders of motor function, already observed at an early age and due to cerebral lesions." | 2.37 | [Functional neurosurgery of cerebral palsy]. ( Alexandre, F; Angelini, L; Benezech, J; Broggi, G; Claverie, P; Deonna, T; Frerebeau, P; Lazorthes, Y; Siegfried, J; Verdie, JC, 1985) |
"To quantify the risk of encephalopathy associated with oral baclofen compared with other muscle relaxants-tizanidine or cyclobenzaprine." | 1.91 | Baclofen and the Risk of Encephalopathy: A Real-World, Active-Comparator Cohort Study. ( Brotman, DJ; Chang, AR; Grams, ME; Hwang, YJ; Inker, LA; Shin, JI, 2023) |
"Hospitalization with encephalopathy occurred in 26 of 360 baclofen users (7." | 1.56 | Baclofen has a risk of encephalopathy in older adults receiving dialysis. ( Bathini, L; Blake, PG; Chauvin, KJ; Dixon, SN; Garg, AX; Kim, RB; McArthur, E; Moist, L; Muanda, FT; Sontrop, JM; Weir, MA, 2020) |
"Baclofen is a centrally acting gamma-aminobutyric acid agonist used for the symptomatic relief of skeletal muscle spasm and spasticity in traumatic spinal cord lesions, multiple sclerosis, cerebral palsy, and stroke." | 1.42 | Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease. ( Ijaz, M; Kashif, M; Marquez, JG; Tariq, H, 2015) |
"05), while baclofen dosage increased (p = 0." | 1.40 | Intrathecal baclofen therapy in children with severe spasticity: Outcome and complications. ( Altermatt, S; Furrer, C; Meyer-Heim, A; Walter, M, 2014) |
"Baclofen is a centrally acting gamma-ammino butyric acid agonist that is used like muscular relaxant in disorders with spasticity and intractable hiccups." | 1.33 | [Baclofen-associated encephalopathy in a hemodialysis patient with hiccups]. ( Butjosa, M; Lladó, A; Poch, E; Quintana, LF; Santamaría, J; Torras, A, 2006) |
"In addition, the lowering of tonic seizure threshold observed with thalamic lesions was reversed by these (-)baclofen injections." | 1.29 | An ascending seizure-controlling pathway in the medial brainstem and thalamus. ( Bardgett, ME; Gray, BC; Miller, JW; Turner, GM, 1993) |
"Macro square wave jerks and pendular nystagmus were mildly suppressed after the intramuscular injection of 100 mg of phenobarbital, the oral intake of sodium valproate of 600 mg/day or baclofen of 60 mg/day." | 1.28 | [Multiple system atrophy with macro square wave jerks and pendular nystagmus]. ( Fukusako, T; Morimatsu, M; Nogaki, H; Yamamoto, K, 1992) |
"We report a case of acute transient encephalopathy with confusion, drowsiness, myoclonic jerks, periodic triphasic sharp wave EEG patterns induced by low doses of baclofen." | 1.28 | Acute transient cerebral intoxication induced by low doses of baclofen. ( Lazzarino, LG; Nicolai, A; Valassi, F, 1991) |
"Acute encephalopathy and an abnormal electroencephalogram with a periodic sharp wave pattern developed in a 58-year-old woman shortly after she received a few doses of baclofen." | 1.27 | Periodic sharp waves in baclofen-induced encephalopathy. ( Benarroch, EE; Hormes, JT; Klass, DW; Rodriguez, M, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (23.33) | 18.7374 |
1990's | 6 (20.00) | 18.2507 |
2000's | 6 (20.00) | 29.6817 |
2010's | 6 (20.00) | 24.3611 |
2020's | 5 (16.67) | 2.80 |
Authors | Studies |
---|---|
Hwang, YJ | 1 |
Chang, AR | 1 |
Brotman, DJ | 1 |
Inker, LA | 1 |
Grams, ME | 1 |
Shin, JI | 1 |
Muanda, FT | 2 |
Sontrop, JM | 2 |
Garg, AX | 2 |
Gold, J | 1 |
Zhao, K | 1 |
Abraham, M | 1 |
Behmer Hansen, R | 1 |
Lad, M | 1 |
Mammis, A | 1 |
Sachan, A | 1 |
Singh, VK | 1 |
Kalita, J | 1 |
Misra, UK | 1 |
Chauvin, KJ | 1 |
Blake, PG | 1 |
Weir, MA | 1 |
Bathini, L | 1 |
Dixon, SN | 1 |
McArthur, E | 1 |
Moist, L | 1 |
Kim, RB | 1 |
Chartier, M | 1 |
Malissin, I | 1 |
Tannous, S | 1 |
Labat, L | 1 |
Risède, P | 1 |
Mégarbane, B | 1 |
Chevillard, L | 1 |
Walter, M | 1 |
Altermatt, S | 1 |
Furrer, C | 1 |
Meyer-Heim, A | 1 |
Ijaz, M | 1 |
Tariq, H | 1 |
Kashif, M | 1 |
Marquez, JG | 1 |
Porter, LM | 1 |
Merrick, SS | 1 |
Katz, KD | 1 |
Bonouvrié, LA | 1 |
van Schie, PE | 1 |
Becher, JG | 1 |
van Ouwerkerk, WJ | 1 |
Vermeulen, RJ | 1 |
Mugglestone, MA | 1 |
Eunson, P | 1 |
Murphy, MS | 1 |
Albright, AL | 1 |
Gilmartin, R | 1 |
Swift, D | 1 |
Krach, LE | 1 |
Ivanhoe, CB | 1 |
McLaughlin, JF | 1 |
Pohl, M | 1 |
Rockstroh, G | 1 |
Rückriem, S | 1 |
Mehrholz, J | 1 |
Pause, M | 1 |
Koch, R | 1 |
Strik, H | 1 |
Signorelli, CD | 1 |
Lavano, A | 1 |
Volpentesta, G | 1 |
Chirchiglia, D | 1 |
Signorelli, F | 1 |
Bono, F | 1 |
Ferraro, G | 1 |
Sibille, M | 1 |
Veltri, C | 1 |
Aloisi, M | 1 |
Piragine, G | 1 |
Serra, S | 1 |
Scola, P | 1 |
Pardatcher, S | 1 |
Pardatcher, K | 1 |
Santangelo, E | 1 |
Darbari, FP | 1 |
Melvin, JJ | 1 |
Piatt, JH | 1 |
Adirim, TA | 1 |
Kothare, SV | 1 |
Quintana, LF | 1 |
Lladó, A | 1 |
Butjosa, M | 1 |
Santamaría, J | 1 |
Torras, A | 1 |
Poch, E | 1 |
Goetz, CG | 1 |
Tanner, CM | 1 |
Klawans, HL | 1 |
Abarbanel, J | 2 |
Herishanu, Y | 2 |
Miller, JW | 1 |
Gray, BC | 1 |
Turner, GM | 1 |
Bardgett, ME | 1 |
Bassilios, N | 1 |
Launay-Vacher, V | 1 |
Mercadal, L | 1 |
Deray, G | 1 |
Burke, DJ | 1 |
Yamamoto, K | 1 |
Fukusako, T | 1 |
Nogaki, H | 1 |
Morimatsu, M | 1 |
Kroin, JS | 1 |
Liu, HC | 1 |
Tsai, SC | 1 |
Liu, TY | 1 |
Chi, CW | 1 |
Lazzarino, LG | 1 |
Nicolai, A | 1 |
Valassi, F | 1 |
Lazorthes, Y | 2 |
Sallerin-Caute, B | 1 |
Verdie, JC | 2 |
Bastide, R | 1 |
Hormes, JT | 1 |
Benarroch, EE | 1 |
Rodriguez, M | 1 |
Klass, DW | 1 |
Siegfried, J | 1 |
Broggi, G | 1 |
Claverie, P | 1 |
Deonna, T | 1 |
Frerebeau, P | 1 |
Alexandre, F | 1 |
Angelini, L | 1 |
Benezech, J | 1 |
Frisher, S | 1 |
Trauner, DA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS): A Randomized, Controlled, Multi-center, Prospective Study Evaluating Dose Reduction in ITB Patients.[NCT04530955] | 92 participants (Anticipated) | Interventional | 2020-09-24 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for baclofen and Brain Disorders
Article | Year |
---|---|
Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Baclofen; Brain Diseases; Electroencephalography; | 2020 |
Intrathecal baclofen for progressive neurological disease in childhood: a systematic review of literature.
Topics: Adolescent; Adult; Baclofen; Brain Diseases; Child; Child, Preschool; Female; Humans; Injections, Sp | 2012 |
Intrathecal drug administration. Present use and future trends.
Topics: Analgesics; Baclofen; Brain Diseases; Humans; Injections, Spinal; Neoplasms; Palliative Care; Spasm; | 1992 |
Advances in drug delivery systems and applications in neurosurgery.
Topics: Adult; Aged; Aged, 80 and over; Animals; Baclofen; Brain Diseases; Equipment Design; Female; Humans; | 1991 |
[Functional neurosurgery of cerebral palsy].
Topics: Adolescent; Adult; Animals; Baclofen; Benzodiazepines; Brain; Brain Diseases; Cerebellar Cortex; Cer | 1985 |
3 trials available for baclofen and Brain Disorders
Article | Year |
---|---|
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
Topics: Adolescent; Baclofen; Brain Diseases; Cerebral Cortex; Child; Dose-Response Relationship, Drug; Foll | 2003 |
Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity.
Topics: Adult; Baclofen; Brain Diseases; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Kn | 2003 |
Intrathecal drug administration. Present use and future trends.
Topics: Analgesics; Baclofen; Brain Diseases; Humans; Injections, Spinal; Neoplasms; Palliative Care; Spasm; | 1992 |
23 other studies available for baclofen and Brain Disorders
Article | Year |
---|---|
Baclofen and the Risk of Encephalopathy: A Real-World, Active-Comparator Cohort Study.
Topics: Adolescent; Adult; Baclofen; Brain Diseases; Cohort Studies; Humans; Muscle Relaxants, Central; Musc | 2023 |
Reviewing the Evidence of the Association Between Baclofen and Encephalopathy.
Topics: Baclofen; Brain Diseases; Electroencephalography; Humans | 2023 |
Baclofen encephalopathy: uncommon side effect of a common drug.
Topics: Aged; Baclofen; Biomarkers; Brain Diseases; Diagnosis, Differential; Electroencephalography; Female; | 2020 |
Baclofen has a risk of encephalopathy in older adults receiving dialysis.
Topics: Aged; Baclofen; Brain Diseases; Cohort Studies; Female; Hospitalization; Humans; Ontario; Renal Dial | 2020 |
Baclofen-induced encephalopathy in overdose - Modeling of the electroencephalographic effect/concentration relationships and contribution of tolerance in the rat.
Topics: Animals; Baclofen; Brain; Brain Diseases; Dose-Response Relationship, Drug; Drug Overdose; Drug Tole | 2018 |
Intrathecal baclofen therapy in children with severe spasticity: Outcome and complications.
Topics: Adolescent; Baclofen; Brain Diseases; Brain Injuries; Child; Child, Preschool; Female; Follow-Up Stu | 2014 |
Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease.
Topics: Baclofen; Brain Diseases; Female; Humans; Kidney Failure, Chronic; Middle Aged; Muscle Hypotonia; Mu | 2015 |
Baclofen Toxicity in a Patient with Hemodialysis-Dependent End-Stage Renal Disease.
Topics: Aged; Ataxia; Back Pain; Baclofen; Brain Diseases; Confusion; Dystonia; Emergency Service, Hospital; | 2017 |
Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance.
Topics: Adolescent; Baclofen; Botulinum Toxins, Type A; Brain Diseases; Cerebral Palsy; Child; Humans; Injec | 2012 |
[Intrathecal baclofen in the treatment of spasticity. Our experience].
Topics: Baclofen; Brain Diseases; GABA Agonists; Humans; Injections, Spinal; Muscle Spasticity; Spinal Cord | 2003 |
Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features.
Topics: Baclofen; Brain Diseases; Cerebral Palsy; Child; Drug Overdose; Electroencephalography; Humans; Inje | 2005 |
[Baclofen-associated encephalopathy in a hemodialysis patient with hiccups].
Topics: Aged; Baclofen; Brain Diseases; Hiccup; Humans; Male; Muscle Relaxants, Central; Renal Dialysis | 2006 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; | 1984 |
[Periodic triphasic EEG waves].
Topics: Baclofen; Brain Diseases; Coma; Electroencephalography; Humans; Hypernatremia; Periodicity; Phenothi | 1982 |
An ascending seizure-controlling pathway in the medial brainstem and thalamus.
Topics: Animals; Arousal; Baclofen; Brain Diseases; Female; Neural Pathways; Rats; Seizures; Sleep; Tegmentu | 1993 |
Baclofen neurotoxicity [correction of unerotoxicity] in a chronic haemodialysis patient.
Topics: Aged; Baclofen; Brain Diseases; Humans; Kidney Failure, Chronic; Male; Neurotoxins; Recovery of Func | 2000 |
An approach to the treatment of spasticity.
Topics: Adrenergic alpha-Antagonists; Baclofen; Brain Diseases; Dantrolene; Diazepam; Humans; Mephenesin; Mu | 1975 |
[Multiple system atrophy with macro square wave jerks and pendular nystagmus].
Topics: Atrophy; Baclofen; Brain Diseases; Diazepam; Electrooculography; Eye Movements; Female; Humans; Midd | 1992 |
Baclofen-induced frontal lobe syndrome: case report.
Topics: Aged; Aged, 80 and over; Baclofen; Behavior; Brain Diseases; Confusion; Electroencephalography; Fron | 1991 |
Acute transient cerebral intoxication induced by low doses of baclofen.
Topics: Acute Disease; Aged; Baclofen; Brain Diseases; Electroencephalography; Evoked Potentials, Auditory, | 1991 |
Periodic sharp waves in baclofen-induced encephalopathy.
Topics: Baclofen; Brain Diseases; Electroencephalography; Female; Humans; Middle Aged; Muscular Diseases; Pa | 1988 |
Encephalopathy associated with baclofen.
Topics: Aged; Baclofen; Brain Diseases; Electroencephalography; Female; Humans; Male | 1985 |
Olivopontocerebellar atrophy with dementia, blindness, and chorea. Response to baclofen.
Topics: Adolescent; Adult; Atrophy; Baclofen; Blindness; Brain Diseases; Cerebellar Diseases; Chorea; Dement | 1985 |